Skip to main content

Table 1 Patient characteristics

From: Association between computed tomography-quantified respiratory muscles and chronic obstructive pulmonary disease: a retrospective study

 

Non-COPD group (n = 168)

COPD group (n = 101)

P-value

Age (yr)

66.27 ± 7.44

72.37 ± 9.72

 < 0.001

Male sex (%)

78.57

68.32

0.082

Body-mass index, kg/m2

23.79 ± 3.35

21.14 ± 3.72

 < 0.001

Smoking status (%)

  

0.01

 Never smoker

52.38

31.68

 

 Former smoker

24.40

43.56

 

 Current smoker

23.21

24.75

 

 Smoking history (pack-yr)

35.86 ± 21.3

39.99 ± 22.74

 

Pulmonary function

 FEV1- % of predicted value

94.67 ± 18.19

46.35 ± 18.83

 < 0.001

 FEV1:FVC ratio

88.8 ± 9.69

54.86 ± 10.76

 < 0.001

 COPD stage (%)

  

-

  GOLD I

-

4.95

 

  GOLD II

-

35.64

 

  GOLD III

-

38.61

 

  GOLD IV

-

20.79

 

 Emphysema (%)

-

84.15

 

 LAA950 (%)

8.76 ± 9.49

32.53 ± 16.36

 < 0.001

  1. Plus-minus values are means ± standard deviation
  2. Abbreviations: COPD Chronic obstructive pulmonary disease, GOLD Global Initiative for Chronic Obstructive Lung Disease, LAA950 Low-attenuation area of the lung with attenuation values below − 950 Hounsfield units on inspiratory